Zobrazeno 1 - 10
of 1 659
pro vyhledávání: '"Vincelette J"'
Autor:
Magat J; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Jones S; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Baridon B; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Agrawal V; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Wong H; Department of Process Sciences, BioMarin Pharmaceutical Inc, Novato, California, USA., Giaramita A; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Mangini L; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Handyside B; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Vitelli C; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Parker M; Department of Process Sciences, BioMarin Pharmaceutical Inc, Novato, California, USA., Yeung N; Department of Process Sciences, BioMarin Pharmaceutical Inc, Novato, California, USA., Zhou Y; Department of Process Sciences, BioMarin Pharmaceutical Inc, Novato, California, USA., Pungor E; Department of Process Sciences, BioMarin Pharmaceutical Inc, Novato, California, USA., Slabodkin I; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Gorostiza O; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Aguilera A; Department of Process Sciences, BioMarin Pharmaceutical Inc, Novato, California, USA., Lo MJ; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Alcozie S; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Christianson TM; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Tiger PMN; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Vincelette J; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Fong S; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Gil G; Department of Process Sciences, BioMarin Pharmaceutical Inc, Novato, California, USA., Hague C; Department of Process Sciences, BioMarin Pharmaceutical Inc, Novato, California, USA., Lawrence R; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Wendt DJ; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Lebowitz JH; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Bunting S; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Bullens S; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Crawford BE; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA., Roy SM; Department of Process Sciences, BioMarin Pharmaceutical Inc, Novato, California, USA., Woloszynek JC; Department of Research, BioMarin Pharmaceutical Inc, Novato, California, USA. Electronic address: josh.woloszynek@gmail.com.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2022 Dec; Vol. 298 (12), pp. 102625. Date of Electronic Publication: 2022 Oct 26.
Autor:
Chen, L. H., Leder, K., Barbre, K. A., Schlagenhauf, P., Libman, M., Keystone, J., Mendelson, M., Gautret, P., Schwartz, E., Shaw, M., Macdonald, S., Mccarthy, A., Connor, B. A., Esposito, D. H., Hamer, D., Wilson, M. E., von Sonnenburg, F., Rothe, C., Kain, K., Boggild, A., Cramer, J., Jordan, S., Vinnemeier, C., Yansouni, C., Chappuis, F., Caumes, E., Perignon, A., Torresi, J., Kanagawa, S., Kato, Y., Grobusch, M., Goorhuis, B., Javelle, E., Kozarsky, P., Wu, H., Yoshimura, Y., Tachikawa, N., Lim, P. -L., Piyaphanee, W., Silachamroon, U., Murphy, H., Pandey, P., Asgeirsson, H., Glans, H., Jensenius, M., Borwein, S., Hale, D., Leung, D., Benson, S., van Genderen, P., Hynes, N., Weber, R., Stauffer, W., Walker, P., Haulman, J., Roesel, D., Mockenhaupt, F., Harms-Zwingenberger, G., Rapp, C., Ficko, C., Vincent, P., Castelli, F., Matteelli, A., Anderson, S., Yates, J., Licitra, C., Klochko, A., Gkrania-Klotsas, E., Warne, B., Lopez-Velez, R., Norman, F., Vincelette, J., Barkati, S., Cahill, J., Mckinley, G., Phu, P. T. H., Perez, C. P., Lalloo, D., Beeching, N., Coyle, C., Hajek, J., Ghesquiere, W., Siu, H., Valdez, L. M., Kelly, P., Hagmann, S., Barnett, E., Hochberg, N., Malvy, D., Duvignaud, A., Kuhn, S.
Publikováno v:
Journal of Travel Medicine
Journal of Travel Medicine, Wiley-Blackwell, 2018, 25, ⟨10.1093/jtm/tax097⟩
Journal of travel medicine, 25(1):tax097. Wiley-Blackwell
Journal of Travel Medicine, 2018, 25, ⟨10.1093/jtm/tax097⟩
Journal of Travel Medicine, Wiley-Blackwell, 2018, 25, ⟨10.1093/jtm/tax097⟩
Journal of travel medicine, 25(1):tax097. Wiley-Blackwell
Journal of Travel Medicine, 2018, 25, ⟨10.1093/jtm/tax097⟩
Background Analysis of a large cohort of business travelers will help clinicians focus on frequent and serious illnesses. We aimed to describe travel-related health problems in business travelers. Methods GeoSentinel Surveillance Network consists of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dc5f9a5061cbd9d9bfd78684750fe39
https://hal.archives-ouvertes.fr/hal-01948126
https://hal.archives-ouvertes.fr/hal-01948126
Autor:
Gautret, P., Harvey, K., Pandey, P., Lim, P. L., Leder, K., Piyaphanee, W., Shaw, M., Mcdonald, S. C., Schwartz, E., Esposito, D. H., Parola, P., Delmont, J., Torresi, J., Brown, G., Yoshimura, Y., Tachikawa, N., Kurai, H., Sagara, H., Von Sonnenburg, F., Kanagawa, S., Kato, Y., Mizunno, Y., Hern, A., Chappuis, F., Loutan, L., Keystone, J. S., Kain, K., Grobusch, M., De Vries, P., Gadroen, K., Using, J., Froberg, G., Libman, M. D., Ward, B., Dick Maclean, J., Rapp, C., Aoun, O., Valdez, L. M., Siu, H., Cramer, J., Burchard, G. -D., Phu, P. T. H., Anderson, N., Batchelor, T., Meisch, D., Jensenius, M., Lalloo, D. G., Beeching, N. J., Stauffer, W., Walker, P., Kass, R., Jean Haulman, N., Roesel, D., Jong, E. C., Wang, A., Eason, J., Kendall, B., Hale, D. C., Anand, R., Gelman, S. S., Chen, L. H., Wilson, M. E., Silachamroon, U., Borwein, S., Van Genderen, P. J., Vincelette, J., Gurtman, A., Kozarsky, P. E., Wu, H., Fairley, J., Franco-Paredes, C., Schlagenhauf, P., Weber, R., Steffen, R., Yates, J., Ansdell, V., Mendelson, M., Vincent, P., Mockenhaupt, F., Harms, G., Perret, C., Valdivieso, F., Doyle, P., Ghesquiere, W., Cahill, J. D., Mckinley, G., Mccarthy, A., Caumes, E., Perignon, A., Anderson, S., Hynes, N. A., Bradley Sack, R., Mckenzie, R., Field, V., Connor, B. A., Muller, R., Freedman, D. O., Hagmann, S., Miller, A. O., Gkrania-Klotsas, E., Tenenboim, S., Jenks, N. P., Kerr, C., Licitra, C., Crespo, A., Castelli, F., Carosi, G., Holtom, P., Goad, J., Anglim, A.
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 4, Pp 569-577 (2015)
Emerging Infectious Diseases
Emerging Infectious Diseases
No demographic characteristics identified who might benefit most from pretravel counseling.
Among travelers, rabies cases are rare, but animal bites are relatively common. To determine which travelers are at highest risk for rabies, we studied 2
Among travelers, rabies cases are rare, but animal bites are relatively common. To determine which travelers are at highest risk for rabies, we studied 2
Autor:
Wilson I; Research and Early Development, 10926BioMarin Pharmaceutical Inc., San Rafael, CA, USA.; Dominican University of California, San Rafael, CA, USA., Vitelli C; Research and Early Development, 10926BioMarin Pharmaceutical Inc., San Rafael, CA, USA., Yu GK; Research and Early Development, 10926BioMarin Pharmaceutical Inc., San Rafael, CA, USA., Pacheco G; Research and Early Development, 10926BioMarin Pharmaceutical Inc., San Rafael, CA, USA., Vincelette J; Research and Early Development, 10926BioMarin Pharmaceutical Inc., San Rafael, CA, USA., Bunting S; Research and Early Development, 10926BioMarin Pharmaceutical Inc., San Rafael, CA, USA., Sisó S; Research and Early Development, 10926BioMarin Pharmaceutical Inc., San Rafael, CA, USA.; Dominican University of California, San Rafael, CA, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2021 Jun; Vol. 49 (4), pp. 950-962. Date of Electronic Publication: 2021 Mar 11.
Publikováno v:
Canadian Journal of Public Health / Revue Canadienne de Sante'e Publique, 1974 May 01. 65(3), 188-190.
Externí odkaz:
https://www.jstor.org/stable/41985891
Autor:
Luu AR, Wong C, Agrawal V, Wise N, Handyside B, Lo MJ, Pacheco G, Felix JB, Giaramita A, d'Azzo A, Vincelette J, Bullens S, Bunting S, Christianson TM, Hague CM, LeBowitz JH, Yogalingam G
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2020 Nov 13; Vol. 295 (46), pp. 15794.
Autor:
McCarthy, A., Libman, M., Yansouni, C., Kuhn, S., Geduld, J., Hajek, J., Ghesquiere, W., Mirzanejad, Y., Plewes, K., Vincelette, J., Barkati, S., Ploude, P., Greenaway, C., Schwartz, K., Thompson, C., Kain, K., Boggild, A.K.
Publikováno v:
In International Journal of Infectious Diseases February 2019 79 Supplement 1:93-94
Autor:
Luu AR; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Wong C; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Agrawal V; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Wise N; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Handyside B; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Lo MJ; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Pacheco G; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Felix JB; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Giaramita A; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., d'Azzo A; Department of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Vincelette J; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Bullens S; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Bunting S; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Christianson TM; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Hague CM; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., LeBowitz JH; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA., Yogalingam G; Research Department, BioMarin Pharmaceutical, Inc., Novato, California, USA. Electronic address: gyogalingam@bmrn.com.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2020 Sep 25; Vol. 295 (39), pp. 13556-13569. Date of Electronic Publication: 2020 Jul 28.
Autor:
Chen JC; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Luu AR; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Wise N; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Angelis R; Process Sciences, BioMarin Pharmaceutical, Inc., Novato, California 94949., Agrawal V; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Mangini L; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Vincelette J; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Handyside B; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Sterling H; Process Sciences, BioMarin Pharmaceutical, Inc., Novato, California 94949., Lo MJ; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Wong H; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Galicia N; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Pacheco G; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Van Vleet J; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Giaramita A; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Fong S; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Roy SM; Process Sciences, BioMarin Pharmaceutical, Inc., Novato, California 94949., Hague C; Process Sciences, BioMarin Pharmaceutical, Inc., Novato, California 94949., Lawrence R; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Bullens S; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Christianson TM; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., d'Azzo A; Department of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105., Crawford BE; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Bunting S; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., LeBowitz JH; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949., Yogalingam G; Research, BioMarin Pharmaceutical, Inc., Novato, California 94949. Electronic address: gyogalingam@bmrn.com.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2020 Sep 25; Vol. 295 (39), pp. 13532-13555. Date of Electronic Publication: 2019 Sep 03.
Autor:
Grover A; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Crippen-Harmon D; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Nave L; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Vincelette J; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Wait JCM; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Melton AC; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Lawrence R; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Brown JR; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Webster KA; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Yip BK; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Baridon B; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Vitelli C; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Rigney S; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Christianson TM; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Tiger PMN; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Lo MJ; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Holtzinger J; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Shaywitz AJ; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Crawford BE; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Fitzpatrick PA; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., LeBowitz JH; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Bullens S; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Aoyagi-Scharber M; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Bunting S; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., O'Neill CA; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA. coneill@bmrn.com., Pinkstaff J; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA., Bagri A; BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA.
Publikováno v:
Drug delivery and translational research [Drug Deliv Transl Res] 2020 Apr; Vol. 10 (2), pp. 425-439.